位置:首页 > 蛋白库 > GPR26_HUMAN
GPR26_HUMAN
ID   GPR26_HUMAN             Reviewed;         337 AA.
AC   Q8NDV2; Q2M2E2;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=G-protein coupled receptor 26;
GN   Name=GPR26;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Jones G., Boulay J.L., Maier D., Merlo A.;
RT   "Sequence of the human homologue of the rat orphan G protein-coupled
RT   receptor GPR26 mRNA.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Boulay J.L., Labuhn M., Jones G., Maier D., Merlo A.;
RT   "The 10q25.3-26.1 gene encoding the orphan G protein-coupled receptor GPR26
RT   is epigenetically silenced in human gliomas.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ARG-104 AND ARG-236.
RX   PubMed=17363172; DOI=10.1016/j.bbagen.2007.01.013;
RA   Jones P.G., Nawoschik S.P., Sreekumar K., Uveges A.J., Tseng E., Zhang L.,
RA   Johnson J., He L., Paulsen J.E., Bates B., Pausch M.H.;
RT   "Tissue distribution and functional analyses of the constitutively active
RT   orphan G protein coupled receptors, GPR26 and GPR78.";
RL   Biochim. Biophys. Acta 1770:890-901(2007).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=18037267; DOI=10.1016/j.mcp.2007.10.002;
RA   Carter A.N., Cole C.L., Playle A.G., Ramsay E.J., Shervington A.A.;
RT   "GPR26: a marker for primary glioblastoma?";
RL   Mol. Cell. Probes 22:133-137(2008).
CC   -!- FUNCTION: Orphan receptor. Displays a significant level of constitutive
CC       activity. Its effect is mediated by G(s)-alpha protein that stimulate
CC       adenylate cyclase, resulting in an elevation of intracellular cAMP.
CC       {ECO:0000269|PubMed:17363172}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the CNS, the highest expression
CC       is seen in the amygdala, hippocampus and thalamus. Weak expression is
CC       detected in testis. Down-regulated in glioblastoma.
CC       {ECO:0000269|PubMed:17363172, ECO:0000269|PubMed:18037267}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ505757; CAD44281.1; -; mRNA.
DR   EMBL; BC112011; AAI12012.1; -; mRNA.
DR   EMBL; BC113462; AAI13463.1; -; mRNA.
DR   CCDS; CCDS7636.1; -.
DR   RefSeq; NP_703143.1; NM_153442.3.
DR   AlphaFoldDB; Q8NDV2; -.
DR   SMR; Q8NDV2; -.
DR   BioGRID; 109108; 1.
DR   CORUM; Q8NDV2; -.
DR   STRING; 9606.ENSP00000284674; -.
DR   ChEMBL; CHEMBL4523895; -.
DR   BioMuta; GPR26; -.
DR   DMDM; 37537804; -.
DR   MassIVE; Q8NDV2; -.
DR   PaxDb; Q8NDV2; -.
DR   PeptideAtlas; Q8NDV2; -.
DR   PRIDE; Q8NDV2; -.
DR   ProteomicsDB; 73057; -.
DR   Antibodypedia; 19086; 174 antibodies from 27 providers.
DR   DNASU; 2849; -.
DR   Ensembl; ENST00000284674.2; ENSP00000284674.1; ENSG00000154478.4.
DR   GeneID; 2849; -.
DR   KEGG; hsa:2849; -.
DR   MANE-Select; ENST00000284674.2; ENSP00000284674.1; NM_153442.4; NP_703143.1.
DR   UCSC; uc001lhh.4; human.
DR   CTD; 2849; -.
DR   DisGeNET; 2849; -.
DR   GeneCards; GPR26; -.
DR   HGNC; HGNC:4481; GPR26.
DR   HPA; ENSG00000154478; Tissue enriched (brain).
DR   MIM; 604847; gene.
DR   neXtProt; NX_Q8NDV2; -.
DR   OpenTargets; ENSG00000154478; -.
DR   PharmGKB; PA28869; -.
DR   VEuPathDB; HostDB:ENSG00000154478; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00950000183001; -.
DR   HOGENOM; CLU_009579_3_5_1; -.
DR   InParanoid; Q8NDV2; -.
DR   OMA; HQYKKTW; -.
DR   OrthoDB; 1039292at2759; -.
DR   PhylomeDB; Q8NDV2; -.
DR   TreeFam; TF332434; -.
DR   PathwayCommons; Q8NDV2; -.
DR   BioGRID-ORCS; 2849; 10 hits in 1061 CRISPR screens.
DR   ChiTaRS; GPR26; human.
DR   GeneWiki; GPR26; -.
DR   GenomeRNAi; 2849; -.
DR   Pharos; Q8NDV2; Tbio.
DR   PRO; PR:Q8NDV2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8NDV2; protein.
DR   Bgee; ENSG00000154478; Expressed in endothelial cell and 103 other tissues.
DR   Genevisible; Q8NDV2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Membrane;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..337
FT                   /note="G-protein coupled receptor 26"
FT                   /id="PRO_0000069545"
FT   TOPO_DOM        1..10
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        11..31
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        32..47
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        48..68
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        69..81
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        82..102
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        103..123
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        124..144
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        145..168
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        169..189
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        190..245
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        246..266
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        267..276
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..297
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        298..337
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DISULFID        79..156
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         104
FT                   /note="R->A: No effect on constitutive activity; when
FT                   associated with E-236."
FT                   /evidence="ECO:0000269|PubMed:17363172"
FT   MUTAGEN         104
FT                   /note="R->Q,E: No effect on constitutive activity."
FT                   /evidence="ECO:0000269|PubMed:17363172"
FT   MUTAGEN         104
FT                   /note="R->Q: No effect on constitutive activity; when
FT                   associated with E-236."
FT                   /evidence="ECO:0000269|PubMed:17363172"
FT   MUTAGEN         236
FT                   /note="R->A,Q: No effect on constitutive activity."
FT                   /evidence="ECO:0000269|PubMed:17363172"
FT   MUTAGEN         236
FT                   /note="R->E: No effect on constitutive activity; when
FT                   associated with A-104. No effect on constitutive activity;
FT                   when associated with Q-104."
FT                   /evidence="ECO:0000269|PubMed:17363172"
SQ   SEQUENCE   337 AA;  37604 MW;  4E04D371505F6D01 CRC64;
     MNSWDAGLAG LLVGTMGVSL LSNALVLLCL LHSADIRRQA PALFTLNLTC GNLLCTVVNM
     PLTLAGVVAQ RQPAGDRLCR LAAFLDTFLA ANSMLSMAAL SIDRWVAVVF PLSYRAKMRL
     RDAALMVAYT WLHALTFPAA ALALSWLGFH QLYASCTLCS RRPDERLRFA VFTGAFHALS
     FLLSFVVLCC TYLKVLKVAR FHCKRIDVIT MQTLVLLVDL HPSVRERCLE EQKRRRQRAT
     KKISTFIGTF LVCFAPYVIT RLVELFSTVP IGSHWGVLSK CLAYSKAASD PFVYSLLRHQ
     YRKSCKEILN RLLHRRSIHS SGLTGDSHSQ NILPVSE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024